International physician survey on management of FOP: a modified Delphi study

Fibrodysplasia ossificans progressiva (FOP), a disabling disorder of progressive heterotopic ossification (HEO), is caused by heterozygous gain-of- function mutations in Activin receptor A, type I (ACVR1, also known as ALK2), a bone morphogenetic protein (BMP) type I receptor. Presently, symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Rocco, Maja, Baujat, Genevieve, Bertamino, Marta, Brown, Matthew, De Cunto, Carmen L., Delai, Patricia L. R., Eekhoff, Elisabeth M. W., Haga, Nobuhiko, Hsiao, Edward, Keen, Richard, Morhart, Rolf, Pignolo, Robert J., Kaplan, Frederick S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468985/
https://www.ncbi.nlm.nih.gov/pubmed/28606101
http://dx.doi.org/10.1186/s13023-017-0659-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468985/
https://www.ncbi.nlm.nih.gov/pubmed/28606101
http://dx.doi.org/10.1186/s13023-017-0659-4

Ejemplares similares